•
Sep 30, 2012

ResMed Q1 2013 Earnings Report

Total Revenue
$340M
Previous year: $315M
+7.9%
EPS
$0.49
Previous year: $0.33
+48.5%
Gross Profit
$209M
Previous year: $185M
+12.7%
Cash and Equivalents
$891M
Previous year: $610M
+46.0%
Free Cash Flow
$64.4M
Previous year: $76.6M
-15.9%
Total Assets
$2.24B
Previous year: $1.94B
+16.0%

ResMed

ResMed